戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 utations cause potentially lethal congenital lipoid adrenal hyperplasia (lipoid CAH).
2 atory protein in 15 patients with congenital lipoid adrenal hyperplasia from 10 countries.
3                               The congenital lipoid adrenal hyperplasia phenotype is the result of tw
4                                   Congenital lipoid adrenal hyperplasia results in severe impairment
5 e StAR gene result in the disease congenital lipoid adrenal hyperplasia, in which steroid hormone bio
6 IPY and ethidium homodimer-2) to detect both lipoid and DNA content in individual particles.
7 ateral clouding of the central cornea, arcus lipoides and/or visible crystalline deposits of choleste
8 AR amino acid replacement mutants that cause lipoid CAH are inactive because of fairly gross errors i
9 acid replacement/deletion mutants that cause lipoid CAH were purified to apparent homogeneity.
10 order lipoid congenital adrenal hyperplasia (lipoid CAH), we used targeted gene disruption to produce
11 ethal congenital lipoid adrenal hyperplasia (lipoid CAH).
12 velop an animal model for the human disorder lipoid congenital adrenal hyperplasia (lipoid CAH), we u
13 the full range of human STAR mutation-driven lipoid congenital adrenal hyperplasia in patients.
14   A point mutant of StAR (A218V) that causes lipoid congenital adrenal hyperplasia was incorporated i
15 s are given for the determination of how the lipoid content, composition, and structure of individual
16    Applications of the procedure to cationic lipoid-DNA complexes are described, and illustrations ar
17 flow fluorometric approach to study cationic lipoid-DNA complexes is presented.
18 mide (DDA) (C(38)H(80)NBr) is a nonantigenic lipoid material.
19 ease who presented with extensive endogenous lipoid pneumonia and life-threatening hypoxia following
20 l and radiologic manifestations of exogenous lipoid pneumonia from an unreported entity and highlight
21    We present a rare case of acute exogenous lipoid pneumonia in a fire-eater who aspirated liquid pa
22                              Acute exogenous lipoid pneumonia is a very rare disease that typically o
23                                    Exogenous lipoid pneumonia is an uncommon condition caused by inha
24                              Acute exogenous lipoid pneumonia is uncommon and typically is caused by
25 ve workup eventually led to the diagnosis of lipoid pneumonia, attributed to an unusual source of inh
26                  Deriving biofuels and other lipoid products from algae is a promising future technol
27                                              Lipoid proteinosis (LP), also known as hyalinosis cutis
28 bilateral amygdala pathology as a sequela of lipoid proteinosis due to Urbach-Wiethe disease.
29                                     However, lipoid proteinosis is clinically heterogeneous with affe
30 ed with a slightly more severe mucocutaneous lipoid proteinosis phenotype, but neurological features
31             The autosomal recessive disorder lipoid proteinosis results from mutations in extracellul
32 tting of extracts from normal human skin and lipoid proteinosis skin (lacking ECM1).
33 d ECM1 in 10 further unrelated patients with lipoid proteinosis to extend genotype-phenotype correlat
34 e expression profile of a variant causal for lipoid proteinosis, and with a simulation study to asses
35 al similarities between lichen sclerosus and lipoid proteinosis, which results from mutations in extr
36  therefore represent a recurrent mutation in lipoid proteinosis.
37  the most common sites for ECM1 mutations in lipoid proteinosis.
38 s also required for the biosynthesis of this lipoid quinone.
39 nd evaluation of dissolving MAPs loaded with Lipoid S 100(R) based mixed micelles.
40 saturated (Phospholipon 90H) or unsaturated (Lipoid S100) phospholipids and characterized for size, p
41 , Phospholipon 90H) and unsaturated soybean (Lipoid S100) phospholipids, in combination with choleste
42 and 80H) and non-hydrogenated phospholipids (Lipoid-S100) in combination with cholesterol.
43 /or binding sites to lysosomal hydrolases or lipoid substrates.
44              Here, by modeling an artificial lipoid-supported porin ensemble, we explore and establis
45 ting the structural properties, particularly lipoid systems, such as niosomes, can increase cellular
46 to C18:0/C10-EPC (and to many other cationic lipoids) was suggested by the phases that evolved when t
47 gested by the phases that evolved when these lipoids were mixed with negatively charged membrane lipi